Key Takeaways Shares of Kenvue, which makes Tylenol, have recovered almost 60% of their losses since Friday night. Investors may have expected President Donald Trump to announce more regulations on Tylenol, which he claimed pregnant women shouldn't take because of a link to autism. The latest action in shares of Tylenol maker Kenvue looks like a version of that, though investors sold first, then bought today. There aren’t safe alternatives for pregnant women who have a fever, which puts mothers and fetuses at risk, the group said. “We see limited judicial risk,” Citi analysts said.